A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...

8:30 a.m.–9:20 a.m. Check-in for the day and connect with fellow STTR members and guests! The confluence of technological advances and social policies has led to rapid digitization of multimodal, ...

When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, just long enough to learn how to do bone marrow transplant. Instead, he ...

The androgen receptor (AR) is the central therapeutic target in advanced prostate cancer. While treatments that directly target AR are effective in prolonging patient survival, aggressive prostate ...

The esophagus is the organ in the throat that moves food from the mouth to the stomach. Esophageal cancers make up approximately 1% of cancer diagnoses in the U.S., making them rare. Because many ...

TakePART-NW (Patients and Research Together-Northwest) is a research program led by Fred Hutch Cancer Center that aims to improve screening, prevention and treatment for cancer and other diseases. The ...

Alter just one section of the protein responsible for making a muscle cell a muscle cell — and it makes nerve cells instead March 19, 2015 • By Dr. Sabrina Richards / Fred Hutch News Service Muscle ...

Fred Hutch research is performed across divisions, with many Human Biology faculty holding joint appointments in Basic Sciences, Clinical Research, and Public Health Sciences, as well as affiliations ...

“As a Seattle native, I have always been aware of the amazing research and innovation at Fred Hutch. When my life was touched by cancer, I knew it was time to get more involved and support this ...

Affiliate Investigator, Hutchinson Institute for Cancer Outcomes Research (HICOR), Fred Hutch Affiliate Investigator Hutchinson Institute for Cancer Outcomes Research (HICOR), Fred Hutch Dr. Mengyang ...